1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374-403.

https://doi.org/10.1016/j.ejca.2012.12.027

PMid:23485231 

2. Deng J, Jackson L, Epstein JB, Migliorati CA, Murphy BA. Dental demineralization and caries in patients with head and neck cancer. Oral Oncol. 2015;51:824-31.

https://doi.org/10.1016/j.oraloncology.2015.06.009

PMid:26198979 

3. Frydrych AM, Slack-Smith LM, Parsons R. Compliance of post-radiation therapy head and neck cancer patients with caries preventive protocols. Aust Dent J. 2017;62:192-9.

https://doi.org/10.1111/adj.12491

PMid:27861968 

4. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209-49.

https://doi.org/10.3322/caac.21660

PMid:33538338 

5. Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6:92.

https://doi.org/10.1038/s41572-020-00224-3

PMid:33243986 PMCid:PMC7944998

6. Wu-Chou YH, Hsieh CH, Liao CT, Lin YT, Fan WL, Yang CH. NOTCH1 mutations as prognostic marker in oral squamous cell carcinoma. Pathol - Res Pract. 2021;223:153474.

https://doi.org/10.1016/j.prp.2021.153474

PMid:33993060 

7. da Cunha Lima AM, Meira IA, Soares MSM, Bonan PRF, Mélo CB, Piagge CSLD. Delay in diagnosis of oral cancer: A systematic review. Med Oral Patol Oral and Cir Bucal. 2021;26:e815-24.

https://doi.org/10.4317/medoral.24808

PMid:34704975 PMCid:PMC8601633

8. Ding X, Zheng Y, Wang Z, Zhang W, Dong Y, Chen W, et al. Expression and oncogenic properties of membranous Notch1 in oral leukoplakia and oral squamous cell carcinoma. Oncol Rep. 2018;39:2584-94.

https://doi.org/10.3892/or.2018.6335

PMid:29620248 PMCid:PMC5983926

9. Sakamoto K. Notch signaling in oral squamous neoplasia. Pathol Int. 2016;66:609-17.

https://doi.org/10.1111/pin.12461

PMid:27671927 

10. Farah CS. Molecular landscape of head and neck cancer and implications for therapy. Ann Transl Med. 2021;9:915.

https://doi.org/10.21037/atm-20-6264

PMid:34164549 PMCid:PMC8184465

11. Gormley M, Creaney G, Schache A, Ingarfield K, Conway DI. Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors. Br Dent J. 2022;233:780-6.

https://doi.org/10.1038/s41415-022-5166-x

PMid:36369568 PMCid:PMC9652141

12. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.

https://doi.org/10.1136/bmj.b2700

PMid:19622552 PMCid:PMC2714672

13. Harbour R, Lowe G, Twaddle S. Scottish Intercollegiate Guidelines Network: the first 15 years (1993-2008). J R Coll Physicians Edinb. 2011;41:163-8.

https://doi.org/10.4997/JRCPE.2011.209

PMid:21677923 

14. AGREE Reporting Checklist: Brouwers MC, Kerkvliet K, Spithoff K, AGREE Next Steps Consortium. The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines. BMJ. 2016;352:i1152.

https://doi.org/10.1136/bmj.i1152

PMid:26957104 PMCid:PMC5118873

15. Guyatt GH, Oxman AD, Schünemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011;64:380-2.

https://doi.org/10.1016/j.jclinepi.2010.09.011

PMid:21185693 

16. McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement. J Clin Epidemiol. 2016;75:40-6.

https://doi.org/10.1016/j.jclinepi.2016.01.021

PMid:27005575